The Keytruda (pembrolizumab) trial has been discontinued - showed no benefit over existing treatments :-(
https://www.empr.com/home/news/drugs-in-the-pipeline/trial-investigating-pembrolizumab-for-hormone-sensitive-prostate-cancer-discontinued
Edited by moderator 15 Feb 2023 at 10:09 | Reason: Not specified
Click through to become a member and gain access to support, information and real time replies.